Assessing the safety of sitagliptin in older participants in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)

類似資料

• Pancreatic safety of sitagliptin in the TECOS Study.
  著者:: Buse, J, 等
  出版事項: (2016)
• Safety of sitagliptin in patients with type 2 diabetes and chronic kidney disease: Outcomes from TECOS.
  著者:: Engel, S, 等
  出版事項: (2017)
• Rationale and design of the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)
  著者:: Bethel, M, 等
  出版事項: (2009)
• Sitagliptin and risk of fractures in type 2 diabetes: Results from the TECOS Trial.
  著者:: Josse, R, 等
  出版事項: (2016)
• Longitudinal medical resources and costs among type 2 diabetes patients participating in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)
  著者:: Reed, S, 等
  出版事項: (2018)